Author:
Cunningham David,Banham S. W.,Soukop M.
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology
Reference6 articles.
1. Atassi G, Dumont P, Vanhaelen C (1984) Characterization of the Activity of ?/?-triglycidylurazol (TGU: NSC-332488): a new antineoplastic compound. Eur J Cancer Clin Oncol 20: 9: 1187?1191
2. Cunningham D, Banham SW, Hutcheon AH, Dorward A, Ahmedzai S, Tansey P, Soukop M, Stevenson RD, Stack BR, Kaye SB, Lucie N, Burnett AK (1985) High-dose cyclophosphamide and VP16 as late dosage intensification therapy for small cell carcinoma of lung. Cancer Chemother Pharmacol 15: 303
3. Hansen SW, Bach F, Hansen HH (1985) Phase 1 study of 1,2,4-triglycidylurazol (TGU, NSC 332488) Proceedings of the Third European Conference on Clinical Oncology, p 20
4. Miller AB, Hoogstraten B, Stequet M, Winkler A (1981) Reporting results of cancer treatment. Cancer 47: 207?214
5. Morstyn G, Ihde DC, Lichter AS, Bunn PA, Carney DN, Glatstein E, Minna JD (1984) Small cell lung cancer 1973?1983: Early progress and recent obstacles. Int J Radiat Oncol Biol Phys 10: 515?539
Cited by
8 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献